AYTU BIOPHARMA, INC (NASDAQ:AYTU) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on February 03, 2026.
The Healthcare company reported Q0 revenue of .
AYTU BIOPHARMA, INC's stock currently trades at $2.62 with a market capitalization of $16.5M.
